Looxid Labs wins CES 2018 innovation awards for mobile VR eye tracking system
Looxid Labs, a US startup working on user emotion recognition system for VR has won a CES 2018 Best of Innovation Award for its mobile-based VR headset.
The company picked up the prestigious award, which puts them in the group as previous winners Tilt Brush and Samsung Gear VR, for its LooxidVR product. The mobile-based VR headset that is similar to the Samsung Gear VR or Google Daydream view, but it contains some potentially revolutionary tech.
The headset is embedded with EEG sensors and eye tracking cameras that are capable of tracking the user’s brain activity, eye movement and pupil dilation. This is done through two eye tracking cameras and six brain-wave sensors and allows the headset to pick up detailed information on where users are looking and how they are reacting to virtual content.
In a press release the company states that:
“LooxidVR allows time-synchronized acquisition of eye and brain data concurrent with VR contents and provides an expandable API, which can be widely applicable in various VR industries that require better understanding of users' emotional status such as stress level, preference, and engagement.”
Looxid Labs has developed an emotion recognition system and an eye and brain interface optimised for VR. With users wearing the headset, the system uses machine learning to detect and classify emotional states. This data can then be applied to various VR applications to help use better awareness of user emotional states in order to develop more immersive VR systems and experiences.
"It is really encouraging to see our technology and potential recognized globally with the Best of Innovation Awards at CES 2018, where the most influential and ingenious consumer technologies are showcased," said Yongwook Chae, the CEO of Looxid Labs.
"Preorder sales of our award-winning product, the LooxidVR, will be kicked off on February 1st, 2018. Our future developments include comprehensive VR user analytics solution based on eye and brain interface."